Obesity White Papers & Case Studies

  1. What Our Portal Does For Sites, Sponsors, And Patients 10/8/2025

    Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.

  2. Program Management 10/7/2025

    With Altasciences, a single program manager oversees your studies from preclinical to early-phase, streamlining communication, accelerating timelines, and reducing stress.

  3. It's Time To Move Into One Home for Sites 10/7/2025

    Explore a vendor- and sponsor-neutral platform that streamlines trial management by consolidating systems and tasks.

  4. Expanding Accessibility In A Phase 3 Influenza Study Through Community-Based Research 10/6/2025

    By meeting participants where they are, this study sets a new benchmark for inclusive, efficient, and impactful vaccine development.

  5. Gene Therapies For Rare Diseases: Platforms, Modalities, And Delivery Systems 10/6/2025

    Examine the treatment landscape for rare diseases and the rapid evolution of gene therapy across three key dimensions: editing platforms, delivery modalities, and delivery vehicles.

  6. Optimize And Expedite Clinical Trial Design, Planning, and Execution 10/3/2025

    Obtain smarter, faster, and more resilient clinical trials that reduce cost, improve outcomes, and bring life-changing therapies to patients sooner with integrated, user-friendly technology.

  7. Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech 10/2/2025

    This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.

  8. Increasing Efficiency And Reducing Drug Waste 10/2/2025

    Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.

  9. Navigating Adverse Immunostimulation: A Practical Guide For Clinical Researchers 9/30/2025

    Explore a systematic approach to evaluate adverse immunostimulation (AIS) in drug development through standardized biomarker sampling and tailored management strategies.

  10. Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays 9/25/2025

    Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.